Quantcast

Keystone Today

Tuesday, November 5, 2024

FDA conducted second lowest number of inspections on Biologics companies in Pennsylvania during Q2 2023

Webp qjor7q6aba3j2gn1lh89sh3yxtfn

DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website

DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website

In the second quarter of 2023, 10 Biologics companies received 10 FDA inspections in Pennsylvania, according to the U.S. Food and Drug Administration (FDA).

This was the second lowest number of inspections per type of company made by the FDA in Pennsylvania, equalling 10.6% of all inspections in the second quarter of 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Top 10 FDA Inspections by Number of Actions Indicated in Pennsylvania During Q2 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Bioresearch Monitoring6----
Blood and Blood Products10----
Compliance: Devices4----
Drug Quality Assurance331
Food Composition, Standards, Labeling and Econ112--
Foodborne Biological Hazards394--
Human Cellular, Tissue, and Gene Therapies5----
Monitoring of Marketed Animal Drugs, Feed, and Devices137--
Technical Assistance: Food and Cosmetics3----
Vaccines and Allergenic Products2----

MORE NEWS